Slideshow
Author(s):
Findings from a new study indicate that compared with children who were not exposed to the drug, children with in utero exposure to sodium valproate have lower scores on national tests at age 7 years.
This Week on NeurologyLive® — May 19, 2025
Episode 141: Refining TSC Care: Phenotyping, Clustering, and Clinical Impact
FDA Clears IND to Study Gene Therapy CAP-002 in STXBP1 Developmental Epileptic Encephalopathy
Episode 139: Sleep and Seizures: Emerging Insights From AAN 2025
This Week on NeurologyLive® — May 12, 2025
FDA Action Update, April 2025: Approvals, Expansion, and Authorization